Home/Filings/4/0001246360-18-000228
4//SEC Filing

Swan Winifred L 4

Accession 0001246360-18-000228

CIK 0001333170other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:07 PM ET

Size

8.1 KB

Accession

0001246360-18-000228

Insider Transaction Report

Form 4
Period: 2018-01-16
Swan Winifred L
SVP and General Counsel
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-01-163,00014,542 total
    Exercise: $11.03From: 2013-04-04Exp: 2023-03-03Common Stock (3,000 underlying)
  • Sale

    Common Stock

    2018-01-16$24.88/sh3,500$87,08010,270 total
  • Exercise/Conversion

    Common Stock

    2018-01-16$11.03/sh+3,000$33,09013,770 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeother

Related Parties

1
  • filerCIK 0001341405

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:07 PM ET
Size
8.1 KB